New Jersey Litigation Adds Mirena Lawsuits to its Case List, While Looking Ahead to Status Conference this Month

Share Article

Bernstein Liebhard LLP is currently offering free and confidential Mirena lawsuit evaluations to women who may have suffered uterine perforations and other injuries following insertion of the IUD.

Free Case Review
As we continue to hear from women who were allegedly injured by the Mirena IUD, our Firm is pleased to see the New Jersey lawsuits moving forward.

A consolidated litigation involving Mirena lawsuits ( is continuing to progress in New Jersey’s Bergen County Superior Court with new additions to its case list and upcoming status conference scheduled to take place this month, Bernstein Liebhard LLP reports.

According to a Case List updated on May 28th, a total of 811 cases involving the Mirena IUD have now been filed in New Jersey on behalf of women who were allegedly injured by the intrauterine contraceptive. Plaintiffs in these cases allege the potential for Mirena to spontaneously migrate away from the uterine wall and into other parts of the body, causing a number of serious complications. Parties in the litigation are also looking ahead to its next status conference, which will be held on June 24, 2014 at 1:00 p.m. (In Re: Mirena Litigation; Case No. 297)

“As we continue to hear from women who were allegedly injured by the Mirena IUD, our Firm is pleased to see the New Jersey lawsuits moving forward," says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including Mirena. The Firm is currently offering free and confidential case reviews to women who allegedly experienced spontaneous migration of the Mirena IUD.

Mirena Lawsuits
Following its U.S. approval in 2000, the Mirena IUD has become widely used by women as both as a contraceptive and treatment for heavy menstrual bleeding. Court documents indicate that the birth control device is also now involved in 1,300 lawsuits filed in the U.S., between two litigations established at the federal and state court levels.

In addition to more than 800 cases now pending in a state proceeding currently underway in New Jersey Superior Court, hundreds of lawsuits that similarly allege spontaneous device migration and other alleged side effects of the IUD are continuing to move forward in a federal multidistrict litigation currently proceeding in New York federal court. According to a Case List updated on May 15th, a total of 528 claims are now pending in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

This progress comes amidst numerous reports of spontaneous IUD migration, uterine perforation and other injuries related to the device. Included in one such report, which was conducted by 7 Action News in Detroit and released in August 2013, are findings that Mirena was named in over 70,000 complaints filed with the U.S. Food and Drug Administration (FDA) since 2000.*

All Mirena IUD lawsuits filed in the U.S. similarly allege that Bayer downplayed risks associated with its product, and overstated its purported benefits. In 2009, the same year the FDA expanded Mirena’s list of approved uses to include the treatment of menstrual bleeding, the federal agency issued a Warning Letter to Bayer that admonished the company for certain promotions of the IUD, which were said to have included claims that were misleading.
Alleged victims of spontaneous IUD migration and related Mirena complications may be eligible to receive compensation for medical bills, lost wages, pain and suffering, and more. Learn more about the litigation involving Mirena IUD lawsuits by visiting Bernstein Liebhard LLP’s website, or when you visit the Firm’s Facebook page: For a free legal consultation, please call 800-511-5092.

*, 7 Action News, August 27, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website